ResearcherJilin UniversityNo recent work listed

Yan Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8607-4363; OpenAlex author ID A5100351118. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2022: 2 papers

Papers 2

MicroRNA-543 controls pancreatic cancer development by LINC00847-microRNA-543-STK31 axis. Co-author DOI 10.21037/jgo-22-1017 ↗
HTR1D functions as a key target of HOXA10-AS/miR-340-3p axis to promote the malignant outcome of pancreatic cancer via PI3K-AKT signaling pathway. Co-author DOI 10.7150/ijbs.70546 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ruizhi Hou · 1 shared paper, 2022 · strength 0.17
- Paper MicroRNA-543 controls pancreatic cancer development by LINC00847-microRNA-543-STK31 axis. DOI 10.21037/jgo-22-1017 ↗
Wu Wu · 1 shared paper, 2022 · strength 0.15
- Paper HTR1D functions as a key target of HOXA10-AS/miR-340-3p axis to promote the malignant outcome of pancreatic cancer via … DOI 10.7150/ijbs.70546 ↗
Jianping Gong · 1 shared paper, 2022 · strength 0.15
- Paper HTR1D functions as a key target of HOXA10-AS/miR-340-3p axis to promote the malignant outcome of pancreatic cancer via … DOI 10.7150/ijbs.70546 ↗
Menghao Wang · 1 shared paper, 2022 · strength 0.15
- Paper HTR1D functions as a key target of HOXA10-AS/miR-340-3p axis to promote the malignant outcome of pancreatic cancer via … DOI 10.7150/ijbs.70546 ↗
Zhu Zhu · 1 shared paper, 2022 · strength 0.15
- Paper HTR1D functions as a key target of HOXA10-AS/miR-340-3p axis to promote the malignant outcome of pancreatic cancer via … DOI 10.7150/ijbs.70546 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.